1 | A bill to be entitled |
2 | An act relating to Medicaid services; amending s. 400.141, |
3 | F.S.; conforming a cross-reference to changes made by the |
4 | act; amending s. 400.23, F.S.; providing for flexibility |
5 | in how to meet the minimum staffing requirements for |
6 | nursing home facilities; amending s. 409.903, F.S.; |
7 | eliminating eligibility and coverage for women during |
8 | pregnancy and the postpartum period who live in a family |
9 | that has an income at or below a specified percentage of |
10 | the federal poverty level; amending s. 409.904, F.S.; |
11 | revising the expiration date of provisions authorizing the |
12 | federal waiver for certain persons age 65 and over or who |
13 | have a disability; revising the expiration date of |
14 | provisions authorizing a specified medically needy |
15 | program; amending s. 409.906, F.S.; eliminating optional |
16 | adult Medicaid coverage for chiropractic services for |
17 | adult recipients; amending s. 409.908, F.S.; updating the |
18 | formula used for calculating reimbursements to providers |
19 | of prescribed drugs; amending s. 409.9082, F.S.; revising |
20 | the purpose of the use of the nursing home facility |
21 | quality assessment and federal matching funds; amending s. |
22 | 409.9083, F.S.; revising the purpose of the use of the |
23 | privately operated intermediate care facilities for the |
24 | developmentally disabled quality assessment and federal |
25 | matching funds; amending s. 409.911, F.S.; updating the |
26 | data to be used in calculating disproportionate share; |
27 | revising the formula used to pay disproportionate share |
28 | dollars to provider service network hospitals; amending s. |
29 | 409.9112, F.S.; continuing the prohibition against |
30 | distributing moneys under the perinatal intensive care |
31 | centers disproportionate share program; amending s. |
32 | 409.9113, F.S.; continuing authorization for the |
33 | distribution of moneys to teaching hospitals under the |
34 | disproportionate share program; amending s. 409.9117, |
35 | F.S.; continuing the prohibition against distributing |
36 | moneys under the primary care disproportionate share |
37 | program; amending s. 409.912, F.S.; updating the formula |
38 | used for calculating reimbursements to providers of |
39 | prescribed drugs; amending s. 430.707, F.S.; permitting |
40 | the Agency for Health Care Administration, in consultation |
41 | with the Department of Elderly Affairs, to accept and |
42 | forward an application for expansion of service capacity |
43 | to the Centers for Medicare and Medicaid Services for a |
44 | specified entity that provides benefits under the Program |
45 | of All-inclusive Care for the Elderly; providing an |
46 | effective date. |
47 |
|
48 | Be It Enacted by the Legislature of the State of Florida: |
49 |
|
50 | Section 1. Paragraph (o) of subsection (1) of section |
51 | 400.141, Florida Statutes, is amended to read: |
52 | 400.141 Administration and management of nursing home |
53 | facilities.- |
54 | (1) Every licensed facility shall comply with all |
55 | applicable standards and rules of the agency and shall: |
56 | (o)1. Submit semiannually to the agency, or more |
57 | frequently if requested by the agency, information regarding |
58 | facility staff-to-resident ratios, staff turnover, and staff |
59 | stability, including information regarding certified nursing |
60 | assistants, licensed nurses, the director of nursing, and the |
61 | facility administrator. For purposes of this reporting: |
62 | a. Staff-to-resident ratios must be reported in the |
63 | categories specified in s. 400.23(3)(a) and applicable rules. |
64 | The ratio must be reported as an average for the most recent |
65 | calendar quarter. |
66 | b. Staff turnover must be reported for the most recent 12- |
67 | month period ending on the last workday of the most recent |
68 | calendar quarter prior to the date the information is submitted. |
69 | The turnover rate must be computed quarterly, with the annual |
70 | rate being the cumulative sum of the quarterly rates. The |
71 | turnover rate is the total number of terminations or separations |
72 | experienced during the quarter, excluding any employee |
73 | terminated during a probationary period of 3 months or less, |
74 | divided by the total number of staff employed at the end of the |
75 | period for which the rate is computed, and expressed as a |
76 | percentage. |
77 | c. The formula for determining staff stability is the |
78 | total number of employees that have been employed for more than |
79 | 12 months, divided by the total number of employees employed at |
80 | the end of the most recent calendar quarter, and expressed as a |
81 | percentage. |
82 | d. A nursing facility that has failed to comply with state |
83 | minimum-staffing requirements for 2 consecutive days is |
84 | prohibited from accepting new admissions until the facility has |
85 | achieved the minimum-staffing requirements for a period of 6 |
86 | consecutive days. For the purposes of this sub-subparagraph, any |
87 | person who was a resident of the facility and was absent from |
88 | the facility for the purpose of receiving medical care at a |
89 | separate location or was on a leave of absence is not considered |
90 | a new admission. Failure to impose such an admissions moratorium |
91 | constitutes a class II deficiency. |
92 | e. A nursing facility which does not have a conditional |
93 | license may be cited for failure to comply with the standards in |
94 | s. 400.23(3)(a)1.b. and c. s. 400.23(3)(a)1.a. only if it has |
95 | failed to meet those standards on 2 consecutive days or if it |
96 | has failed to meet at least 97 percent of those standards on any |
97 | one day. |
98 | f. A facility which has a conditional license must be in |
99 | compliance with the standards in s. 400.23(3)(a) at all times. |
100 | 2. This paragraph does not limit the agency's ability to |
101 | impose a deficiency or take other actions if a facility does not |
102 | have enough staff to meet the residents' needs. |
103 | Section 2. Paragraph (a) of subsection (3) of section |
104 | 400.23, Florida Statutes, is amended to read: |
105 | 400.23 Rules; evaluation and deficiencies; licensure |
106 | status.- |
107 | (3)(a)1. The agency shall adopt rules providing minimum |
108 | staffing requirements for nursing homes. These requirements |
109 | shall include, for each nursing home facility: |
110 | a. A minimum weekly average of certified nursing assistant |
111 | and licensed nursing staffing combined of 3.9 hours of direct |
112 | care per resident per day. As used in this sub-subparagraph, a |
113 | week is defined as Sunday through Saturday. |
114 | b. A minimum certified nursing assistant staffing of 2.7 |
115 | hours of direct care per resident per day. A facility may not |
116 | staff below one certified nursing assistant per 20 residents. |
117 | c. A minimum licensed nursing staffing of 1.0 hour of |
118 | direct care per resident per day. A facility may not staff below |
119 | one licensed nurse per 40 residents. |
120 | a. A minimum certified nursing assistant staffing of 2.6 |
121 | hours of direct care per resident per day beginning January 1, |
122 | 2003, and increasing to 2.7 hours of direct care per resident |
123 | per day beginning January 1, 2007. Beginning January 1, 2002, no |
124 | facility shall staff below one certified nursing assistant per |
125 | 20 residents, and a minimum licensed nursing staffing of 1.0 |
126 | hour of direct care per resident per day but never below one |
127 | licensed nurse per 40 residents. |
128 | b. Beginning January 1, 2007, a minimum weekly average |
129 | certified nursing assistant staffing of 2.9 hours of direct care |
130 | per resident per day. For the purpose of this sub-subparagraph, |
131 | a week is defined as Sunday through Saturday. |
132 | 2. Nursing assistants employed under s. 400.211(2) may be |
133 | included in computing the staffing ratio for certified nursing |
134 | assistants only if their job responsibilities include only |
135 | nursing-assistant-related duties. |
136 | 3. Each nursing home must document compliance with |
137 | staffing standards as required under this paragraph and post |
138 | daily the names of staff on duty for the benefit of facility |
139 | residents and the public. |
140 | 4. The agency shall recognize the use of licensed nurses |
141 | for compliance with minimum staffing requirements for certified |
142 | nursing assistants, provided that the facility otherwise meets |
143 | the minimum staffing requirements for licensed nurses and that |
144 | the licensed nurses are performing the duties of a certified |
145 | nursing assistant. Unless otherwise approved by the agency, |
146 | licensed nurses counted toward the minimum staffing requirements |
147 | for certified nursing assistants must exclusively perform the |
148 | duties of a certified nursing assistant for the entire shift and |
149 | not also be counted toward the minimum staffing requirements for |
150 | licensed nurses. If the agency approved a facility's request to |
151 | use a licensed nurse to perform both licensed nursing and |
152 | certified nursing assistant duties, the facility must allocate |
153 | the amount of staff time specifically spent on certified nursing |
154 | assistant duties for the purpose of documenting compliance with |
155 | minimum staffing requirements for certified and licensed nursing |
156 | staff. In no event may the hours of a licensed nurse with dual |
157 | job responsibilities be counted twice. |
158 | Section 3. Subsection (5) of section 409.903, Florida |
159 | Statutes, is amended to read: |
160 | 409.903 Mandatory payments for eligible persons.-The |
161 | agency shall make payments for medical assistance and related |
162 | services on behalf of the following persons who the department, |
163 | or the Social Security Administration by contract with the |
164 | Department of Children and Family Services, determines to be |
165 | eligible, subject to the income, assets, and categorical |
166 | eligibility tests set forth in federal and state law. Payment on |
167 | behalf of these Medicaid eligible persons is subject to the |
168 | availability of moneys and any limitations established by the |
169 | General Appropriations Act or chapter 216. |
170 | (5) A pregnant woman for the duration of her pregnancy and |
171 | for the postpartum period as defined in federal law and rule, or |
172 | a child under age 1, if either is living in a family that has an |
173 | income which is at or below 150 percent of the most current |
174 | federal poverty level, or, effective January 1, 2011 1992, a |
175 | child under age 1 who is living in a family that has an income |
176 | which is at or below 185 percent of the most current federal |
177 | poverty level. Such a person is not subject to an assets test. |
178 | Further, a pregnant woman who applies for eligibility for the |
179 | Medicaid program through a qualified Medicaid provider must be |
180 | offered the opportunity, subject to federal rules, to be made |
181 | presumptively eligible for the Medicaid program. |
182 | Section 4. Subsections (1) and (2) of section 409.904, |
183 | Florida Statutes, are amended to read: |
184 | 409.904 Optional payments for eligible persons.-The agency |
185 | may make payments for medical assistance and related services on |
186 | behalf of the following persons who are determined to be |
187 | eligible subject to the income, assets, and categorical |
188 | eligibility tests set forth in federal and state law. Payment on |
189 | behalf of these Medicaid eligible persons is subject to the |
190 | availability of moneys and any limitations established by the |
191 | General Appropriations Act or chapter 216. |
192 | (1) Effective January 1, 2006, and subject to federal |
193 | waiver approval, a person who is age 65 or older or is |
194 | determined to be disabled, whose income is at or below 88 |
195 | percent of the federal poverty level, whose assets do not exceed |
196 | established limitations, and who is not eligible for Medicare |
197 | or, if eligible for Medicare, is also eligible for and receiving |
198 | Medicaid-covered institutional care services, hospice services, |
199 | or home and community-based services. The agency shall seek |
200 | federal authorization through a waiver to provide this coverage. |
201 | This subsection expires June 30, 2011 December 31, 2010. |
202 | (2)(a) A family, a pregnant woman, a child under age 21, a |
203 | person age 65 or over, or a blind or disabled person, who would |
204 | be eligible under any group listed in s. 409.903(1), (2), or |
205 | (3), except that the income or assets of such family or person |
206 | exceed established limitations. For a family or person in one of |
207 | these coverage groups, medical expenses are deductible from |
208 | income in accordance with federal requirements in order to make |
209 | a determination of eligibility. A family or person eligible |
210 | under the coverage known as the "medically needy," is eligible |
211 | to receive the same services as other Medicaid recipients, with |
212 | the exception of services in skilled nursing facilities and |
213 | intermediate care facilities for the developmentally disabled. |
214 | This paragraph expires June 30, 2011 December 31, 2010. |
215 | (b) Effective July 1, 2011 January 1, 2011, a pregnant |
216 | woman or a child younger than 21 years of age who would be |
217 | eligible under any group listed in s. 409.903, except that the |
218 | income or assets of such group exceed established limitations. |
219 | For a person in one of these coverage groups, medical expenses |
220 | are deductible from income in accordance with federal |
221 | requirements in order to make a determination of eligibility. A |
222 | person eligible under the coverage known as the "medically |
223 | needy" is eligible to receive the same services as other |
224 | Medicaid recipients, with the exception of services in skilled |
225 | nursing facilities and intermediate care facilities for the |
226 | developmentally disabled. |
227 | Section 5. Subsection (7) of section 409.906, Florida |
228 | Statutes, is amended to read: |
229 | 409.906 Optional Medicaid services.-Subject to specific |
230 | appropriations, the agency may make payments for services which |
231 | are optional to the state under Title XIX of the Social Security |
232 | Act and are furnished by Medicaid providers to recipients who |
233 | are determined to be eligible on the dates on which the services |
234 | were provided. Any optional service that is provided shall be |
235 | provided only when medically necessary and in accordance with |
236 | state and federal law. Optional services rendered by providers |
237 | in mobile units to Medicaid recipients may be restricted or |
238 | prohibited by the agency. Nothing in this section shall be |
239 | construed to prevent or limit the agency from adjusting fees, |
240 | reimbursement rates, lengths of stay, number of visits, or |
241 | number of services, or making any other adjustments necessary to |
242 | comply with the availability of moneys and any limitations or |
243 | directions provided for in the General Appropriations Act or |
244 | chapter 216. If necessary to safeguard the state's systems of |
245 | providing services to elderly and disabled persons and subject |
246 | to the notice and review provisions of s. 216.177, the Governor |
247 | may direct the Agency for Health Care Administration to amend |
248 | the Medicaid state plan to delete the optional Medicaid service |
249 | known as "Intermediate Care Facilities for the Developmentally |
250 | Disabled." Optional services may include: |
251 | (7) CHIROPRACTIC SERVICES.-The agency may pay for manual |
252 | manipulation of the spine and initial services, screening, and X |
253 | rays provided to a recipient under the age of 21 by a licensed |
254 | chiropractic physician. |
255 | Section 6. Subsection (14) of section 409.908, Florida |
256 | Statutes, is amended to read: |
257 | 409.908 Reimbursement of Medicaid providers.-Subject to |
258 | specific appropriations, the agency shall reimburse Medicaid |
259 | providers, in accordance with state and federal law, according |
260 | to methodologies set forth in the rules of the agency and in |
261 | policy manuals and handbooks incorporated by reference therein. |
262 | These methodologies may include fee schedules, reimbursement |
263 | methods based on cost reporting, negotiated fees, competitive |
264 | bidding pursuant to s. 287.057, and other mechanisms the agency |
265 | considers efficient and effective for purchasing services or |
266 | goods on behalf of recipients. If a provider is reimbursed based |
267 | on cost reporting and submits a cost report late and that cost |
268 | report would have been used to set a lower reimbursement rate |
269 | for a rate semester, then the provider's rate for that semester |
270 | shall be retroactively calculated using the new cost report, and |
271 | full payment at the recalculated rate shall be effected |
272 | retroactively. Medicare-granted extensions for filing cost |
273 | reports, if applicable, shall also apply to Medicaid cost |
274 | reports. Payment for Medicaid compensable services made on |
275 | behalf of Medicaid eligible persons is subject to the |
276 | availability of moneys and any limitations or directions |
277 | provided for in the General Appropriations Act or chapter 216. |
278 | Further, nothing in this section shall be construed to prevent |
279 | or limit the agency from adjusting fees, reimbursement rates, |
280 | lengths of stay, number of visits, or number of services, or |
281 | making any other adjustments necessary to comply with the |
282 | availability of moneys and any limitations or directions |
283 | provided for in the General Appropriations Act, provided the |
284 | adjustment is consistent with legislative intent. |
285 | (14) A provider of prescribed drugs shall be reimbursed |
286 | the least of the amount billed by the provider, the provider's |
287 | usual and customary charge, or the Medicaid maximum allowable |
288 | fee established by the agency, plus a dispensing fee. The |
289 | Medicaid maximum allowable fee for ingredient cost shall will be |
290 | based on the lowest lower of: the average wholesale price (AWP) |
291 | minus 16.4 percent, the wholesaler acquisition cost (WAC) plus |
292 | 4.75 percent, the federal upper limit (FUL), the state maximum |
293 | allowable cost (SMAC), or the usual and customary (UAC) charge |
294 | billed by the provider. Effective March 1, 2011, the Medicaid |
295 | maximum allowable fee for ingredient cost shall be based on the |
296 | lowest of: the wholesaler acquisition cost (WAC), the federal |
297 | upper limit (FUL), the state maximum allowable cost (SMAC), or |
298 | the usual and customary (UAC) charge billed by the provider. |
299 | Medicaid providers are required to dispense generic drugs if |
300 | available at lower cost and the agency has not determined that |
301 | the branded product is more cost-effective, unless the |
302 | prescriber has requested and received approval to require the |
303 | branded product. The agency is directed to implement a variable |
304 | dispensing fee for payments for prescribed medicines while |
305 | ensuring continued access for Medicaid recipients. The variable |
306 | dispensing fee may be based upon, but not limited to, either or |
307 | both the volume of prescriptions dispensed by a specific |
308 | pharmacy provider, the volume of prescriptions dispensed to an |
309 | individual recipient, and dispensing of preferred-drug-list |
310 | products. The agency may increase the pharmacy dispensing fee |
311 | authorized by statute and in the annual General Appropriations |
312 | Act by $0.50 for the dispensing of a Medicaid preferred-drug- |
313 | list product and reduce the pharmacy dispensing fee by $0.50 for |
314 | the dispensing of a Medicaid product that is not included on the |
315 | preferred drug list. The agency may establish a supplemental |
316 | pharmaceutical dispensing fee to be paid to providers returning |
317 | unused unit-dose packaged medications to stock and crediting the |
318 | Medicaid program for the ingredient cost of those medications if |
319 | the ingredient costs to be credited exceed the value of the |
320 | supplemental dispensing fee. The agency is authorized to limit |
321 | reimbursement for prescribed medicine in order to comply with |
322 | any limitations or directions provided for in the General |
323 | Appropriations Act, which may include implementing a prospective |
324 | or concurrent utilization review program. |
325 | Section 7. Subsection (4) of section 409.9082, Florida |
326 | Statutes, is amended to read: |
327 | 409.9082 Quality assessment on nursing home facility |
328 | providers; exemptions; purpose; federal approval required; |
329 | remedies.- |
330 | (4) The purpose of the nursing home facility quality |
331 | assessment is to ensure continued quality of care. Collected |
332 | assessment funds shall be used to obtain federal financial |
333 | participation through the Medicaid program to make Medicaid |
334 | payments for nursing home facility services up to the amount of |
335 | nursing home facility Medicaid rates as calculated in accordance |
336 | with the approved state Medicaid plan in effect on December 31, |
337 | 2007. The quality assessment and federal matching funds shall be |
338 | used exclusively for the following purposes and in the following |
339 | order of priority: |
340 | (a) To reimburse the Medicaid share of the quality |
341 | assessment as a pass-through, Medicaid-allowable cost; |
342 | (b) To increase to each nursing home facility's Medicaid |
343 | rate, as needed, an amount that restores the rate reductions |
344 | effective on or after implemented January 1, 2008, as provided |
345 | in the General Appropriations Act; January 1, 2009; and March 1, |
346 | 2009; and |
347 | (c) To increase to each nursing home facility's Medicaid |
348 | rate, as needed, an amount that restores any rate reductions for |
349 | the 2009-2010 fiscal year; and |
350 | (c)(d) To increase each nursing home facility's Medicaid |
351 | rate that accounts for the portion of the total assessment not |
352 | included in paragraphs (a) and (b) (a)-(c) which begins a phase- |
353 | in to a pricing model for the operating cost component. |
354 | Section 8. Subsection (3) of section 409.9083, Florida |
355 | Statutes, is amended to read: |
356 | 409.9083 Quality assessment on privately operated |
357 | intermediate care facilities for the developmentally disabled; |
358 | exemptions; purpose; federal approval required; remedies.- |
359 | (3) The purpose of the facility quality assessment is to |
360 | ensure continued quality of care. Collected assessment funds |
361 | shall be used to obtain federal financial participation through |
362 | the Medicaid program to make Medicaid payments for ICF/DD |
363 | services up to the amount of the Medicaid rates for such |
364 | facilities as calculated in accordance with the approved state |
365 | Medicaid plan in effect on April 1, 2008. The quality assessment |
366 | and federal matching funds shall be used exclusively for the |
367 | following purposes and in the following order of priority to: |
368 | (a) Reimburse the Medicaid share of the quality assessment |
369 | as a pass-through, Medicaid-allowable cost. |
370 | (b) Increase each privately operated ICF/DD Medicaid rate, |
371 | as needed, by an amount that restores the rate reductions |
372 | effective on or after implemented on October 1, 2008, as |
373 | provided in the General Appropriations Act. |
374 | (c) Increase each ICF/DD Medicaid rate, as needed, by an |
375 | amount that restores any rate reductions for the 2008-2009 |
376 | fiscal year and the 2009-2010 fiscal year. |
377 | (c)(d) Increase payments to such facilities to fund |
378 | covered services to Medicaid beneficiaries. |
379 | Section 9. Paragraph (a) of subsection (2) and subsection |
380 | (5) of section 409.911, Florida Statutes, are amended to read: |
381 | 409.911 Disproportionate share program.-Subject to |
382 | specific allocations established within the General |
383 | Appropriations Act and any limitations established pursuant to |
384 | chapter 216, the agency shall distribute, pursuant to this |
385 | section, moneys to hospitals providing a disproportionate share |
386 | of Medicaid or charity care services by making quarterly |
387 | Medicaid payments as required. Notwithstanding the provisions of |
388 | s. 409.915, counties are exempt from contributing toward the |
389 | cost of this special reimbursement for hospitals serving a |
390 | disproportionate share of low-income patients. |
391 | (2) The Agency for Health Care Administration shall use |
392 | the following actual audited data to determine the Medicaid days |
393 | and charity care to be used in calculating the disproportionate |
394 | share payment: |
395 | (a) The average of the 2003, 2004, and 2005, and 2006 |
396 | audited disproportionate share data to determine each hospital's |
397 | Medicaid days and charity care for the 2010-2011 2009-2010 state |
398 | fiscal year. |
399 | (5) The following formula shall be used to pay |
400 | disproportionate share dollars to provider service network (PSN) |
401 | hospitals: |
402 | DSHP = TAAPSNH x (IHPSND/THPSND IHPSND x THPSND) |
403 | Where: |
404 | DSHP = Disproportionate share hospital payments. |
405 | TAAPSNH = Total amount available for PSN hospitals. |
406 | IHPSND = Individual hospital PSN days. |
407 | THPSND = Total of all hospital PSN days. |
408 | For purposes of this subsection, the PSN inpatient days shall be |
409 | provided in the General Appropriations Act. |
410 | Section 10. Section 409.9112, Florida Statutes, is amended |
411 | to read: |
412 | 409.9112 Disproportionate share program for regional |
413 | perinatal intensive care centers.-In addition to the payments |
414 | made under s. 409.911, the agency shall design and implement a |
415 | system for making disproportionate share payments to those |
416 | hospitals that participate in the regional perinatal intensive |
417 | care center program established pursuant to chapter 383. The |
418 | system of payments must conform to federal requirements and |
419 | distribute funds in each fiscal year for which an appropriation |
420 | is made by making quarterly Medicaid payments. Notwithstanding |
421 | s. 409.915, counties are exempt from contributing toward the |
422 | cost of this special reimbursement for hospitals serving a |
423 | disproportionate share of low-income patients. For the 2010-2011 |
424 | 2009-2010 state fiscal year, the agency may not distribute |
425 | moneys under the regional perinatal intensive care centers |
426 | disproportionate share program. |
427 | (1) The following formula shall be used by the agency to |
428 | calculate the total amount earned for hospitals that participate |
429 | in the regional perinatal intensive care center program: |
430 | TAE = HDSP/THDSP |
431 | Where: |
432 | TAE = total amount earned by a regional perinatal intensive |
433 | care center. |
434 | HDSP = the prior state fiscal year regional perinatal |
435 | intensive care center disproportionate share payment to the |
436 | individual hospital. |
437 | THDSP = the prior state fiscal year total regional |
438 | perinatal intensive care center disproportionate share payments |
439 | to all hospitals. |
440 | (2) The total additional payment for hospitals that |
441 | participate in the regional perinatal intensive care center |
442 | program shall be calculated by the agency as follows: |
443 | TAP = TAE x TA |
444 | Where: |
445 | TAP = total additional payment for a regional perinatal |
446 | intensive care center. |
447 | TAE = total amount earned by a regional perinatal intensive |
448 | care center. |
449 | TA = total appropriation for the regional perinatal |
450 | intensive care center disproportionate share program. |
451 | (3) In order to receive payments under this section, a |
452 | hospital must be participating in the regional perinatal |
453 | intensive care center program pursuant to chapter 383 and must |
454 | meet the following additional requirements: |
455 | (a) Agree to conform to all departmental and agency |
456 | requirements to ensure high quality in the provision of |
457 | services, including criteria adopted by departmental and agency |
458 | rule concerning staffing ratios, medical records, standards of |
459 | care, equipment, space, and such other standards and criteria as |
460 | the department and agency deem appropriate as specified by rule. |
461 | (b) Agree to provide information to the department and |
462 | agency, in a form and manner to be prescribed by rule of the |
463 | department and agency, concerning the care provided to all |
464 | patients in neonatal intensive care centers and high-risk |
465 | maternity care. |
466 | (c) Agree to accept all patients for neonatal intensive |
467 | care and high-risk maternity care, regardless of ability to pay, |
468 | on a functional space-available basis. |
469 | (d) Agree to develop arrangements with other maternity and |
470 | neonatal care providers in the hospital's region for the |
471 | appropriate receipt and transfer of patients in need of |
472 | specialized maternity and neonatal intensive care services. |
473 | (e) Agree to establish and provide a developmental |
474 | evaluation and services program for certain high-risk neonates, |
475 | as prescribed and defined by rule of the department. |
476 | (f) Agree to sponsor a program of continuing education in |
477 | perinatal care for health care professionals within the region |
478 | of the hospital, as specified by rule. |
479 | (g) Agree to provide backup and referral services to the |
480 | county health departments and other low-income perinatal |
481 | providers within the hospital's region, including the |
482 | development of written agreements between these organizations |
483 | and the hospital. |
484 | (h) Agree to arrange for transportation for high-risk |
485 | obstetrical patients and neonates in need of transfer from the |
486 | community to the hospital or from the hospital to another more |
487 | appropriate facility. |
488 | (4) Hospitals which fail to comply with any of the |
489 | conditions in subsection (3) or the applicable rules of the |
490 | department and agency may not receive any payments under this |
491 | section until full compliance is achieved. A hospital which is |
492 | not in compliance in two or more consecutive quarters may not |
493 | receive its share of the funds. Any forfeited funds shall be |
494 | distributed by the remaining participating regional perinatal |
495 | intensive care center program hospitals. |
496 | Section 11. Section 409.9113, Florida Statutes, is amended |
497 | to read: |
498 | 409.9113 Disproportionate share program for teaching |
499 | hospitals.-In addition to the payments made under ss. 409.911 |
500 | and 409.9112, the agency shall make disproportionate share |
501 | payments to statutorily defined teaching hospitals for their |
502 | increased costs associated with medical education programs and |
503 | for tertiary health care services provided to the indigent. This |
504 | system of payments must conform to federal requirements and |
505 | distribute funds in each fiscal year for which an appropriation |
506 | is made by making quarterly Medicaid payments. Notwithstanding |
507 | s. 409.915, counties are exempt from contributing toward the |
508 | cost of this special reimbursement for hospitals serving a |
509 | disproportionate share of low-income patients. For the 2010-2011 |
510 | 2009-2010 state fiscal year, the agency shall distribute the |
511 | moneys provided in the General Appropriations Act to statutorily |
512 | defined teaching hospitals and family practice teaching |
513 | hospitals under the teaching hospital disproportionate share |
514 | program. The funds provided for statutorily defined teaching |
515 | hospitals shall be distributed in the same proportion as the |
516 | state fiscal year 2003-2004 teaching hospital disproportionate |
517 | share funds were distributed or as otherwise provided in the |
518 | General Appropriations Act. The funds provided for family |
519 | practice teaching hospitals shall be distributed equally among |
520 | family practice teaching hospitals. |
521 | (1) On or before September 15 of each year, the agency |
522 | shall calculate an allocation fraction to be used for |
523 | distributing funds to state statutory teaching hospitals. |
524 | Subsequent to the end of each quarter of the state fiscal year, |
525 | the agency shall distribute to each statutory teaching hospital, |
526 | as defined in s. 408.07, an amount determined by multiplying |
527 | one-fourth of the funds appropriated for this purpose by the |
528 | Legislature times such hospital's allocation fraction. The |
529 | allocation fraction for each such hospital shall be determined |
530 | by the sum of the following three primary factors, divided by |
531 | three: |
532 | (a) The number of nationally accredited graduate medical |
533 | education programs offered by the hospital, including programs |
534 | accredited by the Accreditation Council for Graduate Medical |
535 | Education and the combined Internal Medicine and Pediatrics |
536 | programs acceptable to both the American Board of Internal |
537 | Medicine and the American Board of Pediatrics at the beginning |
538 | of the state fiscal year preceding the date on which the |
539 | allocation fraction is calculated. The numerical value of this |
540 | factor is the fraction that the hospital represents of the total |
541 | number of programs, where the total is computed for all state |
542 | statutory teaching hospitals. |
543 | (b) The number of full-time equivalent trainees in the |
544 | hospital, which comprises two components: |
545 | 1. The number of trainees enrolled in nationally |
546 | accredited graduate medical education programs, as defined in |
547 | paragraph (a). Full-time equivalents are computed using the |
548 | fraction of the year during which each trainee is primarily |
549 | assigned to the given institution, over the state fiscal year |
550 | preceding the date on which the allocation fraction is |
551 | calculated. The numerical value of this factor is the fraction |
552 | that the hospital represents of the total number of full-time |
553 | equivalent trainees enrolled in accredited graduate programs, |
554 | where the total is computed for all state statutory teaching |
555 | hospitals. |
556 | 2. The number of medical students enrolled in accredited |
557 | colleges of medicine and engaged in clinical activities, |
558 | including required clinical clerkships and clinical electives. |
559 | Full-time equivalents are computed using the fraction of the |
560 | year during which each trainee is primarily assigned to the |
561 | given institution, over the course of the state fiscal year |
562 | preceding the date on which the allocation fraction is |
563 | calculated. The numerical value of this factor is the fraction |
564 | that the given hospital represents of the total number of full- |
565 | time equivalent students enrolled in accredited colleges of |
566 | medicine, where the total is computed for all state statutory |
567 | teaching hospitals. |
568 |
|
569 | The primary factor for full-time equivalent trainees is computed |
570 | as the sum of these two components, divided by two. |
571 | (c) A service index that comprises three components: |
572 | 1. The Agency for Health Care Administration Service |
573 | Index, computed by applying the standard Service Inventory |
574 | Scores established by the agency to services offered by the |
575 | given hospital, as reported on Worksheet A-2 for the last fiscal |
576 | year reported to the agency before the date on which the |
577 | allocation fraction is calculated. The numerical value of this |
578 | factor is the fraction that the given hospital represents of the |
579 | total Agency for Health Care Administration Service Index |
580 | values, where the total is computed for all state statutory |
581 | teaching hospitals. |
582 | 2. A volume-weighted service index, computed by applying |
583 | the standard Service Inventory Scores established by the Agency |
584 | for Health Care Administration to the volume of each service, |
585 | expressed in terms of the standard units of measure reported on |
586 | Worksheet A-2 for the last fiscal year reported to the agency |
587 | before the date on which the allocation factor is calculated. |
588 | The numerical value of this factor is the fraction that the |
589 | given hospital represents of the total volume-weighted service |
590 | index values, where the total is computed for all state |
591 | statutory teaching hospitals. |
592 | 3. Total Medicaid payments to each hospital for direct |
593 | inpatient and outpatient services during the fiscal year |
594 | preceding the date on which the allocation factor is calculated. |
595 | This includes payments made to each hospital for such services |
596 | by Medicaid prepaid health plans, whether the plan was |
597 | administered by the hospital or not. The numerical value of this |
598 | factor is the fraction that each hospital represents of the |
599 | total of such Medicaid payments, where the total is computed for |
600 | all state statutory teaching hospitals. |
601 |
|
602 | The primary factor for the service index is computed as the sum |
603 | of these three components, divided by three. |
604 | (2) By October 1 of each year, the agency shall use the |
605 | following formula to calculate the maximum additional |
606 | disproportionate share payment for statutorily defined teaching |
607 | hospitals: |
608 | TAP = THAF x A |
609 | Where: |
610 | TAP = total additional payment. |
611 | THAF = teaching hospital allocation factor. |
612 | A = amount appropriated for a teaching hospital |
613 | disproportionate share program. |
614 | Section 12. Section 409.9117, Florida Statutes, is amended |
615 | to read: |
616 | 409.9117 Primary care disproportionate share program.-For |
617 | the 2010-2011 2009-2010 state fiscal year, the agency shall not |
618 | distribute moneys under the primary care disproportionate share |
619 | program. |
620 | (1) If federal funds are available for disproportionate |
621 | share programs in addition to those otherwise provided by law, |
622 | there shall be created a primary care disproportionate share |
623 | program. |
624 | (2) The following formula shall be used by the agency to |
625 | calculate the total amount earned for hospitals that participate |
626 | in the primary care disproportionate share program: |
627 | TAE = HDSP/THDSP |
628 | Where: |
629 | TAE = total amount earned by a hospital participating in |
630 | the primary care disproportionate share program. |
631 | HDSP = the prior state fiscal year primary care |
632 | disproportionate share payment to the individual hospital. |
633 | THDSP = the prior state fiscal year total primary care |
634 | disproportionate share payments to all hospitals. |
635 | (3) The total additional payment for hospitals that |
636 | participate in the primary care disproportionate share program |
637 | shall be calculated by the agency as follows: |
638 | TAP = TAE x TA |
639 | Where: |
640 | TAP = total additional payment for a primary care hospital. |
641 | TAE = total amount earned by a primary care hospital. |
642 | TA = total appropriation for the primary care |
643 | disproportionate share program. |
644 | (4) In the establishment and funding of this program, the |
645 | agency shall use the following criteria in addition to those |
646 | specified in s. 409.911, and payments may not be made to a |
647 | hospital unless the hospital agrees to: |
648 | (a) Cooperate with a Medicaid prepaid health plan, if one |
649 | exists in the community. |
650 | (b) Ensure the availability of primary and specialty care |
651 | physicians to Medicaid recipients who are not enrolled in a |
652 | prepaid capitated arrangement and who are in need of access to |
653 | such physicians. |
654 | (c) Coordinate and provide primary care services free of |
655 | charge, except copayments, to all persons with incomes up to 100 |
656 | percent of the federal poverty level who are not otherwise |
657 | covered by Medicaid or another program administered by a |
658 | governmental entity, and to provide such services based on a |
659 | sliding fee scale to all persons with incomes up to 200 percent |
660 | of the federal poverty level who are not otherwise covered by |
661 | Medicaid or another program administered by a governmental |
662 | entity, except that eligibility may be limited to persons who |
663 | reside within a more limited area, as agreed to by the agency |
664 | and the hospital. |
665 | (d) Contract with any federally qualified health center, |
666 | if one exists within the agreed geopolitical boundaries, |
667 | concerning the provision of primary care services, in order to |
668 | guarantee delivery of services in a nonduplicative fashion, and |
669 | to provide for referral arrangements, privileges, and |
670 | admissions, as appropriate. The hospital shall agree to provide |
671 | at an onsite or offsite facility primary care services within 24 |
672 | hours to which all Medicaid recipients and persons eligible |
673 | under this paragraph who do not require emergency room services |
674 | are referred during normal daylight hours. |
675 | (e) Cooperate with the agency, the county, and other |
676 | entities to ensure the provision of certain public health |
677 | services, case management, referral and acceptance of patients, |
678 | and sharing of epidemiological data, as the agency and the |
679 | hospital find mutually necessary and desirable to promote and |
680 | protect the public health within the agreed geopolitical |
681 | boundaries. |
682 | (f) In cooperation with the county in which the hospital |
683 | resides, develop a low-cost, outpatient, prepaid health care |
684 | program to persons who are not eligible for the Medicaid |
685 | program, and who reside within the area. |
686 | (g) Provide inpatient services to residents within the |
687 | area who are not eligible for Medicaid or Medicare, and who do |
688 | not have private health insurance, regardless of ability to pay, |
689 | on the basis of available space, except that hospitals may not |
690 | be prevented from establishing bill collection programs based on |
691 | ability to pay. |
692 | (h) Work with the Florida Healthy Kids Corporation, the |
693 | Florida Health Care Purchasing Cooperative, and business health |
694 | coalitions, as appropriate, to develop a feasibility study and |
695 | plan to provide a low-cost comprehensive health insurance plan |
696 | to persons who reside within the area and who do not have access |
697 | to such a plan. |
698 | (i) Work with public health officials and other experts to |
699 | provide community health education and prevention activities |
700 | designed to promote healthy lifestyles and appropriate use of |
701 | health services. |
702 | (j) Work with the local health council to develop a plan |
703 | for promoting access to affordable health care services for all |
704 | persons who reside within the area, including, but not limited |
705 | to, public health services, primary care services, inpatient |
706 | services, and affordable health insurance generally. |
707 |
|
708 | Any hospital that fails to comply with any of the provisions of |
709 | this subsection, or any other contractual condition, may not |
710 | receive payments under this section until full compliance is |
711 | achieved. |
712 | Section 13. Paragraph (a) of subsection (39) of section |
713 | 409.912, Florida Statutes, is amended to read: |
714 | 409.912 Cost-effective purchasing of health care.-The |
715 | agency shall purchase goods and services for Medicaid recipients |
716 | in the most cost-effective manner consistent with the delivery |
717 | of quality medical care. To ensure that medical services are |
718 | effectively utilized, the agency may, in any case, require a |
719 | confirmation or second physician's opinion of the correct |
720 | diagnosis for purposes of authorizing future services under the |
721 | Medicaid program. This section does not restrict access to |
722 | emergency services or poststabilization care services as defined |
723 | in 42 C.F.R. part 438.114. Such confirmation or second opinion |
724 | shall be rendered in a manner approved by the agency. The agency |
725 | shall maximize the use of prepaid per capita and prepaid |
726 | aggregate fixed-sum basis services when appropriate and other |
727 | alternative service delivery and reimbursement methodologies, |
728 | including competitive bidding pursuant to s. 287.057, designed |
729 | to facilitate the cost-effective purchase of a case-managed |
730 | continuum of care. The agency shall also require providers to |
731 | minimize the exposure of recipients to the need for acute |
732 | inpatient, custodial, and other institutional care and the |
733 | inappropriate or unnecessary use of high-cost services. The |
734 | agency shall contract with a vendor to monitor and evaluate the |
735 | clinical practice patterns of providers in order to identify |
736 | trends that are outside the normal practice patterns of a |
737 | provider's professional peers or the national guidelines of a |
738 | provider's professional association. The vendor must be able to |
739 | provide information and counseling to a provider whose practice |
740 | patterns are outside the norms, in consultation with the agency, |
741 | to improve patient care and reduce inappropriate utilization. |
742 | The agency may mandate prior authorization, drug therapy |
743 | management, or disease management participation for certain |
744 | populations of Medicaid beneficiaries, certain drug classes, or |
745 | particular drugs to prevent fraud, abuse, overuse, and possible |
746 | dangerous drug interactions. The Pharmaceutical and Therapeutics |
747 | Committee shall make recommendations to the agency on drugs for |
748 | which prior authorization is required. The agency shall inform |
749 | the Pharmaceutical and Therapeutics Committee of its decisions |
750 | regarding drugs subject to prior authorization. The agency is |
751 | authorized to limit the entities it contracts with or enrolls as |
752 | Medicaid providers by developing a provider network through |
753 | provider credentialing. The agency may competitively bid single- |
754 | source-provider contracts if procurement of goods or services |
755 | results in demonstrated cost savings to the state without |
756 | limiting access to care. The agency may limit its network based |
757 | on the assessment of beneficiary access to care, provider |
758 | availability, provider quality standards, time and distance |
759 | standards for access to care, the cultural competence of the |
760 | provider network, demographic characteristics of Medicaid |
761 | beneficiaries, practice and provider-to-beneficiary standards, |
762 | appointment wait times, beneficiary use of services, provider |
763 | turnover, provider profiling, provider licensure history, |
764 | previous program integrity investigations and findings, peer |
765 | review, provider Medicaid policy and billing compliance records, |
766 | clinical and medical record audits, and other factors. Providers |
767 | shall not be entitled to enrollment in the Medicaid provider |
768 | network. The agency shall determine instances in which allowing |
769 | Medicaid beneficiaries to purchase durable medical equipment and |
770 | other goods is less expensive to the Medicaid program than long- |
771 | term rental of the equipment or goods. The agency may establish |
772 | rules to facilitate purchases in lieu of long-term rentals in |
773 | order to protect against fraud and abuse in the Medicaid program |
774 | as defined in s. 409.913. The agency may seek federal waivers |
775 | necessary to administer these policies. |
776 | (39)(a) The agency shall implement a Medicaid prescribed- |
777 | drug spending-control program that includes the following |
778 | components: |
779 | 1. A Medicaid preferred drug list, which shall be a |
780 | listing of cost-effective therapeutic options recommended by the |
781 | Medicaid Pharmacy and Therapeutics Committee established |
782 | pursuant to s. 409.91195 and adopted by the agency for each |
783 | therapeutic class on the preferred drug list. At the discretion |
784 | of the committee, and when feasible, the preferred drug list |
785 | should include at least two products in a therapeutic class. The |
786 | agency may post the preferred drug list and updates to the |
787 | preferred drug list on an Internet website without following the |
788 | rulemaking procedures of chapter 120. Antiretroviral agents are |
789 | excluded from the preferred drug list. The agency shall also |
790 | limit the amount of a prescribed drug dispensed to no more than |
791 | a 34-day supply unless the drug products' smallest marketed |
792 | package is greater than a 34-day supply, or the drug is |
793 | determined by the agency to be a maintenance drug in which case |
794 | a 100-day maximum supply may be authorized. The agency is |
795 | authorized to seek any federal waivers necessary to implement |
796 | these cost-control programs and to continue participation in the |
797 | federal Medicaid rebate program, or alternatively to negotiate |
798 | state-only manufacturer rebates. The agency may adopt rules to |
799 | implement this subparagraph. The agency shall continue to |
800 | provide unlimited contraceptive drugs and items. The agency must |
801 | establish procedures to ensure that: |
802 | a. There is a response to a request for prior consultation |
803 | by telephone or other telecommunication device within 24 hours |
804 | after receipt of a request for prior consultation; and |
805 | b. A 72-hour supply of the drug prescribed is provided in |
806 | an emergency or when the agency does not provide a response |
807 | within 24 hours as required by sub-subparagraph a. |
808 | 2. Reimbursement to pharmacies for Medicaid prescribed |
809 | drugs shall be set at the lowest lesser of: the average |
810 | wholesale price (AWP) minus 16.4 percent, the wholesaler |
811 | acquisition cost (WAC) plus 4.75 percent, the federal upper |
812 | limit (FUL), the state maximum allowable cost (SMAC), or the |
813 | usual and customary (UAC) charge billed by the provider. |
814 | Effective March 1, 2011, the Medicaid maximum allowable fee for |
815 | ingredient cost shall be based on the lowest of: the wholesaler |
816 | acquisition costs (WAC), the federal upper limit (FUL), the |
817 | state maximum allowable cost (SMAC), or the usual and customary |
818 | (UAC) charge billed by the provider. |
819 | 3. The agency shall develop and implement a process for |
820 | managing the drug therapies of Medicaid recipients who are using |
821 | significant numbers of prescribed drugs each month. The |
822 | management process may include, but is not limited to, |
823 | comprehensive, physician-directed medical-record reviews, claims |
824 | analyses, and case evaluations to determine the medical |
825 | necessity and appropriateness of a patient's treatment plan and |
826 | drug therapies. The agency may contract with a private |
827 | organization to provide drug-program-management services. The |
828 | Medicaid drug benefit management program shall include |
829 | initiatives to manage drug therapies for HIV/AIDS patients, |
830 | patients using 20 or more unique prescriptions in a 180-day |
831 | period, and the top 1,000 patients in annual spending. The |
832 | agency shall enroll any Medicaid recipient in the drug benefit |
833 | management program if he or she meets the specifications of this |
834 | provision and is not enrolled in a Medicaid health maintenance |
835 | organization. |
836 | 4. The agency may limit the size of its pharmacy network |
837 | based on need, competitive bidding, price negotiations, |
838 | credentialing, or similar criteria. The agency shall give |
839 | special consideration to rural areas in determining the size and |
840 | location of pharmacies included in the Medicaid pharmacy |
841 | network. A pharmacy credentialing process may include criteria |
842 | such as a pharmacy's full-service status, location, size, |
843 | patient educational programs, patient consultation, disease |
844 | management services, and other characteristics. The agency may |
845 | impose a moratorium on Medicaid pharmacy enrollment when it is |
846 | determined that it has a sufficient number of Medicaid- |
847 | participating providers. The agency must allow dispensing |
848 | practitioners to participate as a part of the Medicaid pharmacy |
849 | network regardless of the practitioner's proximity to any other |
850 | entity that is dispensing prescription drugs under the Medicaid |
851 | program. A dispensing practitioner must meet all credentialing |
852 | requirements applicable to his or her practice, as determined by |
853 | the agency. |
854 | 5. The agency shall develop and implement a program that |
855 | requires Medicaid practitioners who prescribe drugs to use a |
856 | counterfeit-proof prescription pad for Medicaid prescriptions. |
857 | The agency shall require the use of standardized counterfeit- |
858 | proof prescription pads by Medicaid-participating prescribers or |
859 | prescribers who write prescriptions for Medicaid recipients. The |
860 | agency may implement the program in targeted geographic areas or |
861 | statewide. |
862 | 6. The agency may enter into arrangements that require |
863 | manufacturers of generic drugs prescribed to Medicaid recipients |
864 | to provide rebates of at least 15.1 percent of the average |
865 | manufacturer price for the manufacturer's generic products. |
866 | These arrangements shall require that if a generic-drug |
867 | manufacturer pays federal rebates for Medicaid-reimbursed drugs |
868 | at a level below 15.1 percent, the manufacturer must provide a |
869 | supplemental rebate to the state in an amount necessary to |
870 | achieve a 15.1-percent rebate level. |
871 | 7. The agency may establish a preferred drug list as |
872 | described in this subsection, and, pursuant to the establishment |
873 | of such preferred drug list, it is authorized to negotiate |
874 | supplemental rebates from manufacturers that are in addition to |
875 | those required by Title XIX of the Social Security Act and at no |
876 | less than 14 percent of the average manufacturer price as |
877 | defined in 42 U.S.C. s. 1936 on the last day of a quarter unless |
878 | the federal or supplemental rebate, or both, equals or exceeds |
879 | 29 percent. There is no upper limit on the supplemental rebates |
880 | the agency may negotiate. The agency may determine that specific |
881 | products, brand-name or generic, are competitive at lower rebate |
882 | percentages. Agreement to pay the minimum supplemental rebate |
883 | percentage will guarantee a manufacturer that the Medicaid |
884 | Pharmaceutical and Therapeutics Committee will consider a |
885 | product for inclusion on the preferred drug list. However, a |
886 | pharmaceutical manufacturer is not guaranteed placement on the |
887 | preferred drug list by simply paying the minimum supplemental |
888 | rebate. Agency decisions shall will be made on the clinical |
889 | efficacy of a drug and recommendations of the Medicaid |
890 | Pharmaceutical and Therapeutics Committee, as well as the price |
891 | of competing products minus federal and state rebates. The |
892 | agency is authorized to contract with an outside agency or |
893 | contractor to conduct negotiations for supplemental rebates. For |
894 | the purposes of this section, the term "supplemental rebates" |
895 | means cash rebates. Effective July 1, 2004, value-added programs |
896 | as a substitution for supplemental rebates are prohibited. The |
897 | agency is authorized to seek any federal waivers to implement |
898 | this initiative. |
899 | 8. The Agency for Health Care Administration shall expand |
900 | home delivery of pharmacy products. To assist Medicaid patients |
901 | in securing their prescriptions and reduce program costs, the |
902 | agency shall expand its current mail-order-pharmacy diabetes- |
903 | supply program to include all generic and brand-name drugs used |
904 | by Medicaid patients with diabetes. Medicaid recipients in the |
905 | current program may obtain nondiabetes drugs on a voluntary |
906 | basis. This initiative is limited to the geographic area covered |
907 | by the current contract. The agency may seek and implement any |
908 | federal waivers necessary to implement this subparagraph. |
909 | 9. The agency shall limit to one dose per month any drug |
910 | prescribed to treat erectile dysfunction. |
911 | 10.a. The agency may implement a Medicaid behavioral drug |
912 | management system. The agency may contract with a vendor that |
913 | has experience in operating behavioral drug management systems |
914 | to implement this program. The agency is authorized to seek |
915 | federal waivers to implement this program. |
916 | b. The agency, in conjunction with the Department of |
917 | Children and Family Services, may implement the Medicaid |
918 | behavioral drug management system that is designed to improve |
919 | the quality of care and behavioral health prescribing practices |
920 | based on best practice guidelines, improve patient adherence to |
921 | medication plans, reduce clinical risk, and lower prescribed |
922 | drug costs and the rate of inappropriate spending on Medicaid |
923 | behavioral drugs. The program may include the following |
924 | elements: |
925 | (I) Provide for the development and adoption of best |
926 | practice guidelines for behavioral health-related drugs such as |
927 | antipsychotics, antidepressants, and medications for treating |
928 | bipolar disorders and other behavioral conditions; translate |
929 | them into practice; review behavioral health prescribers and |
930 | compare their prescribing patterns to a number of indicators |
931 | that are based on national standards; and determine deviations |
932 | from best practice guidelines. |
933 | (II) Implement processes for providing feedback to and |
934 | educating prescribers using best practice educational materials |
935 | and peer-to-peer consultation. |
936 | (III) Assess Medicaid beneficiaries who are outliers in |
937 | their use of behavioral health drugs with regard to the numbers |
938 | and types of drugs taken, drug dosages, combination drug |
939 | therapies, and other indicators of improper use of behavioral |
940 | health drugs. |
941 | (IV) Alert prescribers to patients who fail to refill |
942 | prescriptions in a timely fashion, are prescribed multiple same- |
943 | class behavioral health drugs, and may have other potential |
944 | medication problems. |
945 | (V) Track spending trends for behavioral health drugs and |
946 | deviation from best practice guidelines. |
947 | (VI) Use educational and technological approaches to |
948 | promote best practices, educate consumers, and train prescribers |
949 | in the use of practice guidelines. |
950 | (VII) Disseminate electronic and published materials. |
951 | (VIII) Hold statewide and regional conferences. |
952 | (IX) Implement a disease management program with a model |
953 | quality-based medication component for severely mentally ill |
954 | individuals and emotionally disturbed children who are high |
955 | users of care. |
956 | 11.a. The agency shall implement a Medicaid prescription |
957 | drug management system. The agency may contract with a vendor |
958 | that has experience in operating prescription drug management |
959 | systems in order to implement this system. Any management system |
960 | that is implemented in accordance with this subparagraph must |
961 | rely on cooperation between physicians and pharmacists to |
962 | determine appropriate practice patterns and clinical guidelines |
963 | to improve the prescribing, dispensing, and use of drugs in the |
964 | Medicaid program. The agency may seek federal waivers to |
965 | implement this program. |
966 | b. The drug management system must be designed to improve |
967 | the quality of care and prescribing practices based on best |
968 | practice guidelines, improve patient adherence to medication |
969 | plans, reduce clinical risk, and lower prescribed drug costs and |
970 | the rate of inappropriate spending on Medicaid prescription |
971 | drugs. The program must: |
972 | (I) Provide for the development and adoption of best |
973 | practice guidelines for the prescribing and use of drugs in the |
974 | Medicaid program, including translating best practice guidelines |
975 | into practice; reviewing prescriber patterns and comparing them |
976 | to indicators that are based on national standards and practice |
977 | patterns of clinical peers in their community, statewide, and |
978 | nationally; and determine deviations from best practice |
979 | guidelines. |
980 | (II) Implement processes for providing feedback to and |
981 | educating prescribers using best practice educational materials |
982 | and peer-to-peer consultation. |
983 | (III) Assess Medicaid recipients who are outliers in their |
984 | use of a single or multiple prescription drugs with regard to |
985 | the numbers and types of drugs taken, drug dosages, combination |
986 | drug therapies, and other indicators of improper use of |
987 | prescription drugs. |
988 | (IV) Alert prescribers to patients who fail to refill |
989 | prescriptions in a timely fashion, are prescribed multiple drugs |
990 | that may be redundant or contraindicated, or may have other |
991 | potential medication problems. |
992 | (V) Track spending trends for prescription drugs and |
993 | deviation from best practice guidelines. |
994 | (VI) Use educational and technological approaches to |
995 | promote best practices, educate consumers, and train prescribers |
996 | in the use of practice guidelines. |
997 | (VII) Disseminate electronic and published materials. |
998 | (VIII) Hold statewide and regional conferences. |
999 | (IX) Implement disease management programs in cooperation |
1000 | with physicians and pharmacists, along with a model quality- |
1001 | based medication component for individuals having chronic |
1002 | medical conditions. |
1003 | 12. The agency is authorized to contract for drug rebate |
1004 | administration, including, but not limited to, calculating |
1005 | rebate amounts, invoicing manufacturers, negotiating disputes |
1006 | with manufacturers, and maintaining a database of rebate |
1007 | collections. |
1008 | 13. The agency may specify the preferred daily dosing form |
1009 | or strength for the purpose of promoting best practices with |
1010 | regard to the prescribing of certain drugs as specified in the |
1011 | General Appropriations Act and ensuring cost-effective |
1012 | prescribing practices. |
1013 | 14. The agency may require prior authorization for |
1014 | Medicaid-covered prescribed drugs. The agency may, but is not |
1015 | required to, prior-authorize the use of a product: |
1016 | a. For an indication not approved in labeling; |
1017 | b. To comply with certain clinical guidelines; or |
1018 | c. If the product has the potential for overuse, misuse, |
1019 | or abuse. |
1020 |
|
1021 | The agency may require the prescribing professional to provide |
1022 | information about the rationale and supporting medical evidence |
1023 | for the use of a drug. The agency may post prior authorization |
1024 | criteria and protocol and updates to the list of drugs that are |
1025 | subject to prior authorization on an Internet website without |
1026 | amending its rule or engaging in additional rulemaking. |
1027 | 15. The agency, in conjunction with the Pharmaceutical and |
1028 | Therapeutics Committee, may require age-related prior |
1029 | authorizations for certain prescribed drugs. The agency may |
1030 | preauthorize the use of a drug for a recipient who may not meet |
1031 | the age requirement or may exceed the length of therapy for use |
1032 | of this product as recommended by the manufacturer and approved |
1033 | by the Food and Drug Administration. Prior authorization may |
1034 | require the prescribing professional to provide information |
1035 | about the rationale and supporting medical evidence for the use |
1036 | of a drug. |
1037 | 16. The agency shall implement a step-therapy prior |
1038 | authorization approval process for medications excluded from the |
1039 | preferred drug list. Medications listed on the preferred drug |
1040 | list must be used within the previous 12 months prior to the |
1041 | alternative medications that are not listed. The step-therapy |
1042 | prior authorization may require the prescriber to use the |
1043 | medications of a similar drug class or for a similar medical |
1044 | indication unless contraindicated in the Food and Drug |
1045 | Administration labeling. The trial period between the specified |
1046 | steps may vary according to the medical indication. The step- |
1047 | therapy approval process shall be developed in accordance with |
1048 | the committee as stated in s. 409.91195(7) and (8). A drug |
1049 | product may be approved without meeting the step-therapy prior |
1050 | authorization criteria if the prescribing physician provides the |
1051 | agency with additional written medical or clinical documentation |
1052 | that the product is medically necessary because: |
1053 | a. There is not a drug on the preferred drug list to treat |
1054 | the disease or medical condition which is an acceptable clinical |
1055 | alternative; |
1056 | b. The alternatives have been ineffective in the treatment |
1057 | of the beneficiary's disease; or |
1058 | c. Based on historic evidence and known characteristics of |
1059 | the patient and the drug, the drug is likely to be ineffective, |
1060 | or the number of doses have been ineffective. |
1061 |
|
1062 | The agency shall work with the physician to determine the best |
1063 | alternative for the patient. The agency may adopt rules waiving |
1064 | the requirements for written clinical documentation for specific |
1065 | drugs in limited clinical situations. |
1066 | 17. The agency shall implement a return and reuse program |
1067 | for drugs dispensed by pharmacies to institutional recipients, |
1068 | which includes payment of a $5 restocking fee for the |
1069 | implementation and operation of the program. The return and |
1070 | reuse program shall be implemented electronically and in a |
1071 | manner that promotes efficiency. The program must permit a |
1072 | pharmacy to exclude drugs from the program if it is not |
1073 | practical or cost-effective for the drug to be included and must |
1074 | provide for the return to inventory of drugs that cannot be |
1075 | credited or returned in a cost-effective manner. The agency |
1076 | shall determine if the program has reduced the amount of |
1077 | Medicaid prescription drugs which are destroyed on an annual |
1078 | basis and if there are additional ways to ensure more |
1079 | prescription drugs are not destroyed which could safely be |
1080 | reused. The agency's conclusion and recommendations shall be |
1081 | reported to the Legislature by December 1, 2005. |
1082 | Section 14. Subsection (3) is added to section 430.707, |
1083 | Florida Statutes, to read: |
1084 | 430.707 Contracts.- |
1085 | (3) Any entity that provides or is authorized by state law |
1086 | to provide benefits pursuant to the Program of All-inclusive |
1087 | Care for the Elderly on or before July 1, 2010, may submit an |
1088 | application for an expansion of service capacity sufficient to |
1089 | meet the needs of potentially eligible program enrollees within |
1090 | the service area designated by state law. The agency, in |
1091 | consultation with the department, shall accept and forward to |
1092 | the Centers for Medicare and Medicaid Services the application |
1093 | for an expansion of service capacity for additional enrollees |
1094 | from an entity that provides benefits pursuant to the Program of |
1095 | All-inclusive Care for the Elderly and that is in good standing |
1096 | with the agency, the department, and the Centers for Medicare |
1097 | and Medicaid Services. |
1098 | Section 15. This act shall take effect July 1, 2010. |